{"transactions":[{"id":1216896,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"officer":true,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-07T21:24:16.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":107500,"derivative":{"exercise_price":14.95,"expiration_date":"2035-03-05","underlying":"Ordinary Shares","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0000905148-25-000881","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514825000881/form4.xml","form_type":"4"}},{"id":1594267,"issuer":{"id":2375,"kind":"organization","name":"PROTHENA CORP PUBLIC LTD CO","symbol":"PRTA"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"officer":true,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T02:03:16.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 1, 2025 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":85000,"derivative":{"exercise_price":28.53,"expiration_date":"2034-03-01","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000905148-24-000889","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559053/000090514824000889/form4.xml","form_type":"4"}},{"id":1743614,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":29.46,"underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743613,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":99.66,"underlying":"Common Stock","underlying_shares":5900},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743612,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":110.8,"underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743611,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":110.8,"underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743610,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":58.74,"underlying":"Common Stock","underlying_shares":3},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743609,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6463,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":58.74,"underlying":"Common Stock","underlying_shares":6463},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743608,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8520,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":114.9,"underlying":"Common Stock","underlying_shares":8520},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743607,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3480,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":114.9,"underlying":"Common Stock","underlying_shares":3480},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743606,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":18.4,"underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743605,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":14.44,"underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743604,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21400,"price":19,"value":406600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Company Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Company Common Stock subject to such RSU. Such payment right will vest and become payable in accordance with vesting schedule (including any vesting acceleration provisions) that applied to the corresponding portion of the applicable RSUs immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":1743603,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-11-13T14:42:50.000Z","date":"2023-11-08","kind":"other","planned":false,"acquired":false,"shares":15038,"price":19,"value":285722.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 26, 2023, among the Issuer, Alfasigma S.p.A. (\"Alfasigma\"), and Interstellar Acquisition Inc., a wholly owned subsidiary of Alfasigma (\"Purchaser\"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (\"Company Common Stock\") and thereafter merged with and into the Issuer, effective as of November 8, 2023 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right to receive $19.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-117100","document":"tm2330435-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923117100/tm2330435-3_4seq1.xml","form_type":"4"}},{"id":2040118,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-01-31T16:04:30.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2023."}],"balance_after":16000,"derivative":{"exercise_price":18.4,"expiration_date":"2033-01-27","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-23-008584","document":"tm234878-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008584/tm234878-3_4seq1.xml","form_type":"4"}},{"id":2040117,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-01-31T16:04:30.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":9800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2023."}],"balance_after":36438,"source":{"system":"sec-edgar","filing":"0001104659-23-008584","document":"tm234878-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923008584/tm234878-3_4seq1.xml","form_type":"4"}},{"id":2072348,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2023-01-03T16:02:03.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":1777,"price":12.37,"value":21981.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":26638,"source":{"system":"sec-edgar","filing":"0001104659-23-000330","document":"tm231319-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465923000330/tm231319-3_4seq1.xml","form_type":"4"}},{"id":2420995,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-31T16:14:47.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2022."}],"balance_after":11300,"derivative":{"exercise_price":14.44,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001104659-22-009558","document":"tm224882-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009558/tm224882-5_4seq1.xml","form_type":"4"}},{"id":2420994,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-01-31T16:14:47.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2022."}],"balance_after":28415,"source":{"system":"sec-edgar","filing":"0001104659-22-009558","document":"tm224882-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009558/tm224882-5_4seq1.xml","form_type":"4"}},{"id":2448244,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:17:33.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":106,"price":16.29,"value":1726.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":21815,"source":{"system":"sec-edgar","filing":"0001104659-22-000923","document":"tm221409d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000923/tm221409d3_4.xml","form_type":"4"}},{"id":2448243,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:17:33.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":1606,"price":16.29,"value":26161.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":21921,"source":{"system":"sec-edgar","filing":"0001104659-22-000923","document":"tm221409d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922000923/tm221409d3_4.xml","form_type":"4"}},{"id":2548473,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-10-05T17:28:40.000Z","date":"2021-10-01","kind":"tax_withholding","acquired":false,"shares":92,"price":15.22,"value":1400.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":23527,"source":{"system":"sec-edgar","filing":"0001104659-21-123210","document":"tm2129255d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921123210/tm2129255d2_4seq1.xml","form_type":"4"}},{"id":2644093,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-07-02T19:01:00.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":92,"price":20.47,"value":1883.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":23619,"source":{"system":"sec-edgar","filing":"0001104659-21-089032","document":"tm2121399-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921089032/tm2121399-2_4seq1.xml","form_type":"4"}},{"id":2718324,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-05-11T19:00:25.000Z","date":"2021-05-08","kind":"tax_withholding","acquired":false,"shares":128,"price":17.15,"value":2195.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":23711,"source":{"system":"sec-edgar","filing":"0001104659-21-064695","document":"tm2115919-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921064695/tm2115919-1_4seq1.xml","form_type":"4"}},{"id":2757345,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-04-05T19:02:55.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":92,"price":24.28,"value":2233.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":23839,"source":{"system":"sec-edgar","filing":"0001104659-21-046700","document":"tm2111402-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921046700/tm2111402-4_4seq1.xml","form_type":"4"}},{"id":2868852,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-02-10T19:00:48.000Z","date":"2021-02-08","kind":"tax_withholding","acquired":false,"shares":148,"price":36.04,"value":5333.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":23931,"source":{"system":"sec-edgar","filing":"0001104659-21-020007","document":"tm215983d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921020007/tm215983d1_4.xml","form_type":"4"}},{"id":2895005,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-26T19:01:32.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2021."}],"balance_after":18000,"derivative":{"exercise_price":29.46,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-007780","document":"tm214232d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007780/tm214232d4_4.xml","form_type":"4"}},{"id":2895004,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-01-26T19:01:32.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2021."}],"balance_after":24079,"source":{"system":"sec-edgar","filing":"0001104659-21-007780","document":"tm214232d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921007780/tm214232d4_4.xml","form_type":"4"}},{"id":2919922,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-01-05T19:01:03.000Z","date":"2021-01-01","kind":"tax_withholding","acquired":false,"shares":106,"price":24.7,"value":2618.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":12579,"source":{"system":"sec-edgar","filing":"0001104659-21-001122","document":"tm211606-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001122/tm211606-4_4seq1.xml","form_type":"4"}},{"id":2919921,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2021-01-05T19:01:03.000Z","date":"2020-12-31","kind":"tax_withholding","acquired":false,"shares":629,"price":24.7,"value":15536.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person."}],"balance_after":12685,"source":{"system":"sec-edgar","filing":"0001104659-21-001122","document":"tm211606-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921001122/tm211606-4_4seq1.xml","form_type":"4"}},{"id":2986319,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-11-10T19:00:16.000Z","date":"2020-11-08","kind":"tax_withholding","acquired":false,"shares":128,"price":28.15,"value":3603.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":13314,"source":{"system":"sec-edgar","filing":"0001104659-20-123704","document":"tm2035590d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920123704/tm2035590d1_4.xml","form_type":"4"}},{"id":3012863,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-10-05T19:00:43.000Z","date":"2020-10-01","kind":"tax_withholding","acquired":false,"shares":92,"price":42.08,"value":3871.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":13442,"source":{"system":"sec-edgar","filing":"0001104659-20-112316","document":"tm2032461d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920112316/tm2032461d1_4.xml","form_type":"4"}},{"id":3061709,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-08-11T19:00:27.000Z","date":"2020-08-08","kind":"tax_withholding","acquired":false,"shares":128,"price":48.75,"value":6240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":13534,"source":{"system":"sec-edgar","filing":"0001104659-20-093397","document":"tm2027122d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920093397/tm2027122d1_4.xml","form_type":"4"}},{"id":3088511,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-07-06T19:01:16.000Z","date":"2020-07-01","kind":"tax_withholding","acquired":false,"shares":92,"price":46.52,"value":4279.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":13662,"source":{"system":"sec-edgar","filing":"0001104659-20-081435","document":"tm2024073d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920081435/tm2024073d4_4.xml","form_type":"4"}},{"id":3152440,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-05-12T19:02:59.000Z","date":"2020-05-08","kind":"tax_withholding","acquired":false,"shares":128,"price":87.8,"value":11238.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":13754,"source":{"system":"sec-edgar","filing":"0001104659-20-060294","document":"tm2019428d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920060294/tm2019428d1_4.xml","form_type":"4"}},{"id":3178432,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-04-10T19:00:26.000Z","date":"2020-04-09","kind":"sale","acquired":false,"shares":58,"price":70,"value":4060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":13882,"source":{"system":"sec-edgar","filing":"0001104659-20-045621","document":"tm2015640d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920045621/tm2015640d1_4.xml","form_type":"4"}},{"id":3182785,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-04-03T19:02:59.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":92,"price":58.4,"value":5372.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":13940,"source":{"system":"sec-edgar","filing":"0001104659-20-043286","document":"tm2014981d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920043286/tm2014981d4_4.xml","form_type":"4"}},{"id":3279606,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-02-11T19:00:23.000Z","date":"2020-02-08","kind":"tax_withholding","acquired":false,"shares":148,"price":95.17,"value":14085.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":14032,"source":{"system":"sec-edgar","filing":"0001104659-20-016893","document":"tm207520d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920016893/tm207520d1_4.xml","form_type":"4"}},{"id":3301194,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-01-27T19:05:34.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":5900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2020."}],"balance_after":5900,"derivative":{"exercise_price":99.66,"expiration_date":"2030-01-23","underlying":"Common Stock","underlying_shares":5900},"source":{"system":"sec-edgar","filing":"0001104659-20-007265","document":"tm205922d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007265/tm205922d6_4.xml","form_type":"4"}},{"id":3301193,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-01-27T19:05:34.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2020."}],"balance_after":14180,"source":{"system":"sec-edgar","filing":"0001104659-20-007265","document":"tm205922d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920007265/tm205922d6_4.xml","form_type":"4"}},{"id":3322320,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":259,"price":117.16,"value":30344.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":10580,"source":{"system":"sec-edgar","filing":"0001104659-20-001085","document":"tm201209d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001085/tm201209d2_4.xml","form_type":"4"}},{"id":3322319,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2020-01-01","kind":"tax_withholding","acquired":false,"shares":106,"price":123.92,"value":13135.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":10839,"source":{"system":"sec-edgar","filing":"0001104659-20-001085","document":"tm201209d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001085/tm201209d2_4.xml","form_type":"4"}},{"id":3322318,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2020-01-03T19:00:51.000Z","date":"2019-12-31","kind":"tax_withholding","acquired":false,"shares":323,"price":123.92,"value":40026.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":10945,"source":{"system":"sec-edgar","filing":"0001104659-20-001085","document":"tm201209d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465920001085/tm201209d2_4.xml","form_type":"4"}},{"id":3374237,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-11-12T19:00:21.000Z","date":"2019-11-08","kind":"tax_withholding","acquired":false,"shares":128,"price":82.76,"value":10593.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":11268,"source":{"system":"sec-edgar","filing":"0001104659-19-062781","document":"tm1922493d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919062781/tm1922493d1_4.xml","form_type":"4"}},{"id":3387727,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-10-25T19:00:34.000Z","date":"2019-10-23","kind":"sale","acquired":false,"shares":58,"price":70,"value":4060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11396,"source":{"system":"sec-edgar","filing":"0001104659-19-056609","document":"tm1920920d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465919056609/tm1920920d1_4.xml","form_type":"4"}},{"id":3398312,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-10-03T19:04:25.000Z","date":"2019-10-01","kind":"tax_withholding","acquired":false,"shares":92,"price":65.87,"value":6060.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":11454,"source":{"system":"sec-edgar","filing":"0001144204-19-047225","document":"tv530565_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419047225/tv530565_4.xml","form_type":"4"}},{"id":3410699,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-09-18T19:00:32.000Z","date":"2019-09-16","kind":"sale","acquired":false,"shares":800,"price":70,"value":56000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":11546,"source":{"system":"sec-edgar","filing":"0001144204-19-045112","document":"tv529591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419045112/tv529591_4.xml","form_type":"4"}},{"id":3442241,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-08-09T19:00:33.000Z","date":"2019-08-08","kind":"tax_withholding","acquired":false,"shares":128,"price":66.05,"value":8454.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":12346,"source":{"system":"sec-edgar","filing":"0001144204-19-038975","document":"tv527281_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419038975/tv527281_4.xml","form_type":"4"}},{"id":3467684,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-07-03T17:00:41.000Z","date":"2019-07-01","kind":"tax_withholding","acquired":false,"shares":92,"price":79.17,"value":7283.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":12474,"source":{"system":"sec-edgar","filing":"0001144204-19-033815","document":"tv524734_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419033815/tv524734_form4.xml","form_type":"4"}},{"id":3531299,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-05-10T19:00:21.000Z","date":"2019-05-08","kind":"tax_withholding","acquired":false,"shares":128,"price":87.57,"value":11208.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person."}],"balance_after":12566,"source":{"system":"sec-edgar","filing":"0001144204-19-025390","document":"tv521144_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419025390/tv521144_4.xml","form_type":"4"}},{"id":3564217,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-04-03T19:00:25.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":92,"price":111.5,"value":10258.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":12694,"source":{"system":"sec-edgar","filing":"0001144204-19-018078","document":"tv517924_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419018078/tv517924_4.xml","form_type":"4"}},{"id":3665667,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-02-11T19:00:17.000Z","date":"2019-02-08","kind":"tax_withholding","acquired":false,"shares":125,"price":118.9,"value":14862.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the vesting of restricted stock."}],"balance_after":12786,"source":{"system":"sec-edgar","filing":"0001144204-19-006326","document":"tv513107_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419006326/tv513107_4.xml","form_type":"4"}},{"id":3691640,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-18T19:02:16.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2019."}],"balance_after":6100,"derivative":{"exercise_price":110.8,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001144204-19-002139","document":"tv511180_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002139/tv511180_4.xml","form_type":"4"}},{"id":3691639,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-01-18T19:02:16.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2019."}],"balance_after":12911,"source":{"system":"sec-edgar","filing":"0001144204-19-002139","document":"tv511180_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419002139/tv511180_4.xml","form_type":"4"}},{"id":3708146,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2019-01-03T19:02:07.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":423,"price":100.79,"value":42634.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock units."}],"balance_after":9111,"source":{"system":"sec-edgar","filing":"0001144204-19-000498","document":"tv510189_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420419000498/tv510189_form4.xml","form_type":"4"}},{"id":3769390,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2018-11-09T19:00:12.000Z","date":"2018-11-08","kind":"tax_withholding","acquired":false,"shares":128,"price":113.79,"value":14565.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."}],"balance_after":9534,"source":{"system":"sec-edgar","filing":"0001144204-18-058848","document":"tv506891_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418058848/tv506891_4.xml","form_type":"4"}},{"id":3798293,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:00:54.000Z","date":"2018-08-08","kind":"tax_withholding","acquired":false,"shares":128,"price":116.84,"value":14955.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":9662,"source":{"system":"sec-edgar","filing":"0001144204-18-052404","document":"tv503772_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052404/tv503772_4.xml","form_type":"4"}},{"id":3798292,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2018-10-03T19:00:54.000Z","date":"2018-05-08","kind":"tax_withholding","acquired":false,"shares":510,"price":70.15,"value":35776.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4."}],"balance_after":9662,"source":{"system":"sec-edgar","filing":"0001144204-18-052404","document":"tv503772_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418052404/tv503772_4.xml","form_type":"4"}},{"id":4039919,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-22T21:02:37.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on January 1, 2019, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":6600,"derivative":{"exercise_price":58.74,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0001144204-18-010362","document":"tv486826_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010362/tv486826_4.xml","form_type":"4"}},{"id":4039918,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2018-02-22T21:02:37.000Z","date":"2018-02-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying restricted stock units (\"RSUs\") granted on February 5, 2018, with each RSU representing the contingent right to receive one share of common stock upon vesting of the RSU. 25% of the shares of common stock underlying these RSUs will vest on January 1, 2019, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remainder of the shares of common stock underlying the RSUs will vest pro rata on every subsequent three-month anniversary of the initial vesting date through January 1, 2022 (representing the vesting on each such vesting date of 6.25% of the shares of common stock initially underlying these RSUs), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":10300,"source":{"system":"sec-edgar","filing":"0001144204-18-010362","document":"tv486826_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420418010362/tv486826_4.xml","form_type":"4"}},{"id":4326476,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2017-05-10T21:05:22.000Z","date":"2017-05-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares of common stock underlying this option will vest on May 8, 2018, subject to the terms and conditions of the award and the 2012 Plan. The remainder of the shares of common stock underlying this option will vest pro rata on a monthly basis after the initial vesting date through May 8, 2021 (representing the vesting on each such vesting date of approximately 2.0833% of the shares of common stock initially underlying this option), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":12000,"derivative":{"exercise_price":114.9,"expiration_date":"2027-05-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001144204-17-026209","document":"v466626_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417026209/v466626_form4.xml","form_type":"4"}},{"id":4326475,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":82231,"kind":"person","name":"Ford David A","position":1,"cik":"0001705295","reported_name":"Ford David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"Common Stock","published_at":"2017-05-10T21:05:22.000Z","date":"2017-05-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares of restricted stock will vest on May 8, 2018, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the \"2012 Plan\"). The remaining shares of restricted stock will vest pro rata on every subsequent three-month anniversary of the initial vesting date through May 8, 2021 (representing the vesting on each such vesting date of 6.25% of the shares of restricted stock), subject to the terms and conditions of the award and the 2012 Plan."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001144204-17-026209","document":"v466626_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000114420417026209/v466626_form4.xml","form_type":"4"}}]}